Publication | Closed Access

Delayed administration of a potent cyclin dependent kinase and glycogen synthase kinase 3 β inhibitor produces long-term neuroprotection in a hypoxia-ischemia model of brain injury

Cerebral Vascular RegulationReperfusion InjuryMedicineHypoxia (Medicine)Hypoxia-ischemia ModelCell DeathNeuropharmacologyNeuroprotectionNeurologyNeuroscienceBrain InjuryCerebral Blood FlowDelayed AdministrationPharmacologyIschemic SyndromeOxidative Stress